Therese Starr
Impact in
-
- Antibiotic Use and Resistance
- Pharmacology top 1%
- Antibiotics Pharmacokinetics and Efficacy
Papers in
- Pharmacology 17
- Antibiotics Pharmacokinetics and Efficacy 17
-
- Antibiotic Use and Resistance 6
- Co-authors
- Jeffrey Lipman (22 shared papers)Jason A. Roberts (20 shared papers)Janine Stuart (17 shared papers)Melissa Lassig‐Smith (13 shared papers)Steven C. Wallis (14 shared papers)Paul Max Jarrett (9 shared papers)Andrew Alexander Udy (7 shared papers)Joel M. Dulhunty (7 shared papers)
In The Last Decade
Therese Starr
29 papers receiving 1.2k citations
Therese Starr's Hit Papers
Peers
Comparison fields: 5 of 76
- Applied Microbiology and Biotechnology 171
- Pharmacology 654
- Molecular Medicine 180
- Nephrology 119
- Critical Care and Intensive Care Medicine 77
Countries citing papers authored by Therese Starr
This map shows the geographic impact of Therese Starr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Therese Starr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Therese Starr more than expected).
Fields of papers citing papers by Therese Starr
This network shows the impact of papers produced by Therese Starr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Therese Starr. The network helps show where Therese Starr may publish in the future.
Co-authors
The 25 scholars most cited alongside Therese Starr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 214 | |
| 2 | 2020 | 110 | |
| 3 | 2017 | 93 | |
| 4 | Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis Hit paper breakdown → | 2024 | 88 |
| 5 | 2014 | 66 | |
| 6 | 2017 | 65 | |
| 7 | 2016 | 56 | |
| 8 | 2016 | 47 | |
| 9 | 2019 | 46 | |
| 10 | 2013 | 46 | |
| 11 | 2016 | 44 | |
| 12 | 2016 | 44 | |
| 13 | 2019 | 42 | |
| 14 | 2020 | 33 | |
| 15 | 2019 | 31 | |
| 16 | 2019 | 28 | |
| 17 | 2018 | 22 | |
| 18 | 2016 | 21 | |
| 19 | 2020 | 20 | |
| 20 | 2013 | 20 |
About Therese Starr
Therese Starr is a scholar working on Pharmacology, Applied Microbiology and Biotechnology, Molecular Medicine, Nephrology and Infectious Diseases, having authored 32 papers that have together received 1.2k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (17 papers), Antibiotic Resistance in Bacteria (6 papers), Antibiotic Use and Resistance (6 papers), Antifungal resistance and susceptibility (4 papers), Pneumonia and Respiratory Infections (3 papers), Acute Kidney Injury Research (3 papers), Adrenal Hormones and Disorders (2 papers) and Hemodynamic Monitoring and Therapy (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (171 citations), Pharmacology (654 citations), Molecular Medicine (180 citations), Nephrology (119 citations) and Critical Care and Intensive Care Medicine (77 citations). Therese Starr has collaborated with scholars based in Australia, France and Hong Kong. Frequent co-authors include Jeffrey Lipman, Jason A. Roberts, Janine Stuart, Melissa Lassig‐Smith, Steven C. Wallis, Paul Max Jarrett, Andrew Alexander Udy, Joel M. Dulhunty, John Myburgh and Joshua Saul Davis. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Critical Care and Resuscitation, International Journal of Antimicrobial Agents, Critical Care and Journal of Critical Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.